| Companies sponsors |
• EQRx (sugemalimab) |
| Others |
• Department of Health and Social Care |
| |
• NHS England |
| |
• Welsh Government |
| Patient carer groups |
• Roy Castle Lung Cancer Foundation |
| Professional groups |
• Association of Cancer Physicians |
| |
• British Thoracic Oncology Group |
| |
• British Thoracic Society |
| |
• Cancer Research UK |
| |
• Royal College of Physicians |
| |
• Royal College of Radiologists |
| Comparator companies |
• Accord Healthcare (cisplatin, carboplatin, docetaxel, gemcitabine, paclitaxel, pemetrexed, vinorelbine) (confidentiality agreement not signed, not participating) |
| |
• Aspire Pharma (pemetrexed) (confidentiality agreement not signed, not participating) |
| |
• Celgene (paclitaxel) (confidentiality agreement not signed, not participating) |
| |
• Eli Lilly (pemetrexed) |
| |
• Genus Pharmaceuticals (bevacizumab, pemetrexed) (confidentiality agreement not signed, not participating) |
| |
• Hospira (cisplatin, carboplatin, docetaxel, gemcitabine, paclitaxel) (confidentiality agreement not signed, not participating) |
| |
• Medac GmbH (vinorelbine) |
| |
• Merck, Sharp & Dohme (pembrolizumab) |
| |
• Organon Pharma (bevacizumab) (confidentiality agreement not signed, not participating) |
| |
• Pfizer (bevacizumab) |
| |
• Pierre Fabre (vinorelbine) (confidentiality agreement not signed, not participating) |
| |
• Roche (atezolizumab, bevacizumab) (confidentiality agreement not signed, not participating) |
| |
• Sandoz (cisplatin, pemetrexed) (confidentiality agreement not signed, not participating) |
| |
• Sanofi (cemiplimab) |
| |
• Seacross Pharmaceuticals (docetaxel, paclitaxel, pemetrexed) (confidentiality agreement not signed, not participating) |
| |
• Sun Pharma (gemcitabine, pemetrexed) (confidentiality agreement not signed, not participating) |
| |
• Teva UK (carboplatin, paclitaxel) (confidentiality agreement not signed, not participating) |
| |
• Zentiva Pharma UK (bevacizumab, pemetrexed) (confidentiality agreement not signed, not participating) |
| General commentators |
• All Wales Therapeutics and Toxicology Centre |
| |
• British National Formulary |
| |
• Department of Health, Social Services and Public Safety for Northern Ireland |
| |
• Healthcare Improvement Scotland |
| |
• Scottish Medicines Consortium |
| |
• Welsh Health Specialised Services Committee |
| Relevant research groups |
• Institute of Cancer Research |